Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...

The Center in Asbury Park wants people to "Come Early, Stand Proud, and Walk Strong" on May 4 for the New Jersey AIDS Walk ...

Long-acting injectable HIV treatment leads to rectal shedding in a small proportion of patients with HIV, independent of the ...

A former top federal health official who served during President Trump’s first term warned that the drastic cuts to the ...

Demonstrators gathered Thursday on the steps of the Department of Health and Human Services (HHS) building for a “die-in” ...

A modeling study looked at how anticipated cuts to international HIV funding would affect the rate of new cases and ...

Gilead Sciences' Q1 2025 earnings reveal challenges in oncology and Veklury sales, while HIV therapies remain strong. See why ...

Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the ...

A mathematical modeling study coordinated by UMC Utrecht has shown that sustained HIV remission (without rebound) or HIV ...

A Delray Beach man pleaded guilty to conspiracy to commit wire fraud for his role in a national scheme to distribute ...

The Trump Administration has gutted many areas of healthcare funding and research, especially in infectious diseases. One ...

Dallas is at the center of an urgent public health crisis. The city has the highest rate of new HIV infections in Texas, ...